Answers are grounded in this paper and cite their sources.
Anatomically oriented transcatheter heart valves designed for transapical implantation aim to reduce complications such as paravalvular regurgitation and coronary obstruction.
Transcatheter aortic valve implantation (TAVI) is an accepted treatment option for elderly high-risk patients with aortic valve stenosis (1). Obvious advantages are the avoidance of a sternotomy and cardio-pulmonary bypass. Two devices are mainly used, the SapienTM Valve (Edwards Lifesience, USA) and the CoreValveTM (Medtronic, USA). The SapienTM prosthesis is implanted either transfemorally or transapically whereas the CoreValveTM prosthesis is almost exclusively implanted transfemorally. A major concern in TAVI procedures is malpositioning of the valve prosthesis which can lead to paravalvular or transvalvular regurgitation (AR) (2), or cause coronary obstruction (CO) (3). CO is a rare but severe complication occurring at a rate of 1 to 2% (4,5). In contrast, paravalvular regurgitation is relatively common: In the patient population from the German transcatheter aortic valve interventions registry, almost one fifth of the patients showed moderate to severe AR immediately after implantation. AR was a strong independent predictor of in hospital death but no follow-up data were published (6). The 2 year follow-up results of the Partner trial showed that moderate or severe paravalvular leakage as seen in 6.9% of patients post TAVI was associated with an increase in late mortality and directly correlated with the severity of the paravalvular leakage (7). Those results underline the importance of a perfect placement of transcatheter aortic valve prostheses. To address those complications three devices have been launched lately: The Medtronic EngagerTM System, the Symetis AccurateTM Valve and the JenaValveTM. All three valves are designed for transapical implantation and have different mechanisms to facilitate positioning in an anatomically oriented position.
No takes yet. Share an insight, caveat, or question.
Sündermann et al. (2012) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: